Anti-angiogenic activity of azathioprine.
Microvasc Res
; 138: 104234, 2021 11.
Article
en En
| MEDLINE
| ID: mdl-34478745
ABSTRACT
Azathioprine (AZA) is the main drug used in immunomodulatory therapy in post-transplant patients or with autoimmune diseases. However, no study has evaluated the AZA angiogenic response. Therefore, this study investigated the effects of AZA on the angiogenic process through macroscopic, histological, and immunohistochemical analyses in chick embryo chorioallantoic membrane (CAM). Our results showed potent anti-angiogenic activity of AZA at the higher concentrations tested in the CAM assay. The histological analysis of CAM confirmed this effect, since AZA induced a significant reduction in all parameters evaluated. In addition, immunohistochemical evaluation of CAM revealed that AZA decreased TGF-ß and VEGF levels, important cytokines involved in the angiogenic process. Therefore, the AZA anti-angiogenic effect identified in our study provides new information for the possible application of this drug in anticancer treatment.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Azatioprina
/
Vasos Sanguíneos
/
Neovascularización Fisiológica
/
Inhibidores de la Angiogénesis
/
Membrana Corioalantoides
Tipo de estudio:
Prognostic_studies
Límite:
Animals
Idioma:
En
Revista:
Microvasc Res
Año:
2021
Tipo del documento:
Article
País de afiliación:
Brasil